Incannex Healthcare has said its PSX-001 oral synthetic psilocybin programme [...]

Life Biosciences has raised $80m in a Series D financing [...]

Levicept has reported Phase 2 clinical trial results for LEVI-04 [...]

From hospital haematology to leading early stage clinical trials, Margaret [...]

  The FDA has granted breakthrough therapy designation to Hemab [...]

Long-term VIVID-2 data show more than 90% of patients with [...]

Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]

Evinova and Bristol Myers Squibb have entered a strategic collaboration [...]

Quest Diagnostics has introduced a new blood-based test for measurable [...]

Kayentis and Ametris have announced a strategic partnership to integrate [...]